These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10235085)

  • 1. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.
    Sueta CA; Chowdhury M; Boccuzzi SJ; Smith SC; Alexander CM; Londhe A; Lulla A; Simpson RJ
    Am J Cardiol; 1999 May; 83(9):1303-7. PubMed ID: 10235085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure.
    Sueta CA; Massing MW; Chowdhury M; Biggs DP; Simpson RJ
    J Card Fail; 2003 Feb; 9(1):36-41. PubMed ID: 12612871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
    Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
    Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
    LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting.
    Lacy CR; Suh DC; Barone JA; Bueno M; Moylan D; Swartz C; Kudipudi RV; Kostis JB
    Arch Intern Med; 2002 Feb; 162(4):468-73. PubMed ID: 11863482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction.
    Simpson RJ; Sueta CA; Boccuzzi SJ; Lulla A; Biggs D; Londhe A; Smith SC
    Am J Cardiol; 1997 Oct; 80(8B):53H-56H. PubMed ID: 9372999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians.
    McKee SP; Leslie SJ; LeMaitre JP; Webb DJ; Denvir MA
    Eur J Heart Fail; 2003 Aug; 5(4):549-55. PubMed ID: 12921818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease.
    Harnick DJ; Cohen JL; Schechter CB; Fuster V; Smith DA
    Am J Cardiol; 1998 Jun; 81(12):1416-20. PubMed ID: 9645890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
    Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA; Egger A
    J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists.
    Bramlet DA; King H; Young L; Witt JR; Stoukides CA; Kaul AF
    Am J Cardiol; 1997 Oct; 80(8B):39H-44H. PubMed ID: 9372997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underutilisation of ACE inhibitors in patients with congestive heart failure.
    Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT
    Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
    J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Provider and Practice Volume to Performance Measure Adherence for Coronary Artery Disease, Heart Failure, and Atrial Fibrillation: Results From the National Cardiovascular Data Registry.
    Fleming LM; Jones P; Chan PS; Andrei AC; Maddox TM; Farmer SA
    Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):48-54. PubMed ID: 26646817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.
    Philbin EF; Andreaou C; Rocco TA; Lynch LJ; Baker SL
    Am J Cardiol; 1996 Apr; 77(10):832-8. PubMed ID: 8623735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease.
    Majumdar SR; Gurwitz JH; Soumerai SB
    J Gen Intern Med; 1999 Dec; 14(12):711-7. PubMed ID: 10632815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of congestive heart failure treatment at a Canadian teaching hospital.
    Weil E; Tu JV
    CMAJ; 2001 Aug; 165(3):284-7. PubMed ID: 11517643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.